← Open Payments lookup

KAILA SAXE: Open Payments

NPI 1336491737 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$515 in 22 payments from 11 companies in 2025. Trend: 2023 $368 · 2024 $963 · 2025 $515

Food & beverage: $515
CompanyPaymentsAmount
GlaxoSmithKline, LLC.1$122
PFIZER INC.4$100
Dexcom, Inc.3$57
Novo Nordisk Inc3$52
Amgen Inc.3$46
Lilly USA, LLC2$32
Exact Sciences Corporation2$30
Merck Sharp & Dohme LLC1$22
IBSA Pharma Inc.1$20
ABBVIE INC.1$20

Products named: AREXVY, NURTEC ODT, Dexcom G6 Transmitter, MOUNJARO, Ozempic, PREVNAR 20, OTEZLA, GARDASIL 9.

Industry payments across TX — which companies pay providers there.